Diminished cap formation in lymphocytes from patients and carriers of Duchenne muscular dystrophy.
Open Access
- 1 December 1977
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 23 (12) , 2341-2343
- https://doi.org/10.1093/clinchem/23.12.2341
Abstract
Currently, the most useful clinical laboratory aid in establishing the carrier state of Duchenne muscular dystrophy is to determine creatine kinase (EC 2.7.3.2) activity in the plasma. The considerable overlap between plasma creatine kinase activities of controls and of carriers at the childbearing age contributes appreciable difficulty to genetic counseling of potential carriers. The consistent failure of lymphocyte cap formation in Duchenne muscular dystrophy patients and carriers in this study suggests a valuable tool for the confirmation of the carrier state.This publication has 7 references indexed in Scilit:
- Mechanisms of cellular enzyme release. I. Alteration in membrane fluidity and permeability.Clinical Chemistry, 1977
- Mechanisms of cellular enzyme release. II. Inhibition of sarcolemmal enzymes by myopathy-inducing agents.Clinical Chemistry, 1977
- Duchenne Dystrophy: Alteration in Muscle Plasma Membrane StructureScience, 1977
- Sarcolemmal membrane changes related to enzyme release in the imipramine/serotonin experimental animal model.Clinical Chemistry, 1976
- The Cancer Cell: Dynamic Aspects and Modifications in Cell-Surface OrganizationNew England Journal of Medicine, 1976
- Transmembrane control of the receptors on normal and tumor cellsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1976
- The carrier state in muscular dystrophy of the Duchenne typeJAMA, 1965